Cardiex
Company Details
Status: Public
Employees: 11-50
Location:
55 Lime Street, Suite 301, Sydney, Australia, AU
Type:
sample
sample
Technology:
sample
sample
sample
About: Cardiex Limited (ASX:CDX) is a medical technology company listed on the ASX, focusing on non-invasive vascular health monitoring and digital biomarker solutions for cardiovascular disease management. The company specializes in technologies that measure arterial stiffness and central blood pressure, addressing global cardiovascular health challenges.
Cardiex develops FDA-cleared medical devices and digital health solutions aimed at assessing cardiovascular risk, detecting early disease onset, and monitoring treatment efficacy. Its flagship product, the SphygmoCor® system, is recognized for measuring central aortic pressures and arterial stiffness. The company offers services such as clinical decision support, clinical trial solutions, remote patient monitoring, and research partnerships, targeting healthcare providers, clinical trials, researchers, and consumers.
With a commitment to reducing the global burden of cardiovascular disease, Cardiex has seen significant revenue growth and has established partnerships to enhance wearable technology adoption. Its product lineup includes the CONNEQT Pulse, a connected vascular biometric monitor, and the Arty™ App for remote patient monitoring, among others.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Cardiex | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.